Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
PUT
KeyCorp
KEY
$24.4B
| $292K | ﹤0.01% |
24,000
-39,800
| -62% | -$462K |
|
3727
RB Global
RBA
$17.5B
| $292K | ﹤0.01% |
7,136
-11,364
| -61% | -$465K |
|
3728
PUT
Trinity Industries
TRN
$2.38B
| $292K | ﹤0.01% |
13,700
-15,800
| -54% | -$304K |
|
3729
PUT
Allstate
ALL
$67.5B
| $291K | ﹤0.01% |
3,000
-14,900
| -83% | -$1.46M |
|
3730
CALL
Lincoln National
LNC
$8.81B
| $291K | ﹤0.01% |
7,900
-14,300
| -64% | -$503K |
|
|
3731
PUT
Lincoln National
LNC
$8.81B
| $291K | ﹤0.01% |
7,900
-29,300
| -79% | -$1.03M |
|
3732
PUT
McKesson
MCK
$101B
| $291K | ﹤0.01% |
1,900
-86,100
| -98% | -$12.4M |
|
|
WRK
3733
PUT
DELISTED
WestRock Company
WRK
| $291K | ﹤0.01% |
10,300
-24,700
| -71% | -$702K |
|
3734
CALL
Akamai
AKAM
$16.1B
| $289K | ﹤0.01% |
2,700
-5,900
| -69% | -$593K |
|
3735
Ardelyx
ARDX
$988M
| $289K | ﹤0.01% |
41,530
+20,479
| +97% | +$142K |
|
3736
CytomX Therapeutics
CTMX
$753M
| $289K | ﹤0.01% |
34,662
+11,295
| +48% | +$105K |
|
3737
Webster Financial
WBS
$12.8B
| $289K | ﹤0.01% |
10,147
-8,825
| -47% | -$234K |
|
|
EIGI
3738
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $289K | ﹤0.01% |
71,831
+8,626
| +14% | +$25.5K |
|
|
FONR
3739
DELISTED
Fonar
FONR
| $288K | ﹤0.01% |
+13,480
| New | +$276K |
|
|
WCC
3740
CALL
WESCO International
WCC
$17.7B
| $288K | ﹤0.01% |
8,200
-2,400
| -23% | -$71.7K |
|
3741
Lexicon Pharmaceuticals
LXRX
$1.1B
| $287K | ﹤0.01% |
143,029
+72,550
| +103% | +$142K |
|
3742
CALL
Ally Financial
ALLY
$13.3B
| $286K | ﹤0.01% |
14,400
-18,600
| -56% | -$316K |
|
3743
PUT
Advance Auto Parts
AAP
$3.49B
| $285K | ﹤0.01% |
2,000
-14,600
| -88% | -$1.86M |
|
|
MMP
3744
PUT
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $285K | ﹤0.01% |
6,600
-19,300
| -75% | -$815K |
|
|
PRTK
3745
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $285K | ﹤0.01% |
54,546
+43,515
| +394% | +$193K |
|
|
TTM
3746
PUT
DELISTED
Tata Motors Limited
TTM
| $285K | ﹤0.01% |
43,400
-19,500
| -31% | -$112K |
|
3747
PUT
Digital Realty Trust
DLR
$71.7B
| $284K | ﹤0.01% |
2,000
-19,500
| -91% | -$2.76M |
|
3748
NI Holdings
NODK
$320M
| $284K | ﹤0.01% |
19,244
+8,029
| +72% | +$109K |
|
|
WOW
3749
DELISTED
WideOpenWest
WOW
| $284K | ﹤0.01% |
53,668
+27,848
| +108% | +$157K |
|
3750
Ashland
ASH
$3.5B
| $283K | ﹤0.01% |
4,099
-31,279
| -88% | -$1.94M |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.